Labcorp price target lowered to $244 from $255 at Baird

Baird analyst Eric Coldwell lowered the firm’s price target on Labcorp to $244 from $255 and keeps an Outperform rating on the shares. The firm said they are displeased with the Invitae acquisition dilution and Early Development performance. Otherwise, the company posted another strong result and outlook in its core LCD segment and underappreciated Central Lab.